Related Experiment Videos

The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex

S B Long1, P J Casey, L S Beese

  • 1Department of Biochemistry, PO Box 3711, Duke University Medical Center, Durham, 27710, USA.

Abstract

Insights

Protein farnesyltransferase (FTase) is crucial for Ras signaling and cancer. This study reveals FTase-Ras peptide complexes, highlighting zinc

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Background:

  • Protein farnesyltransferase (FTase) is essential for cellular signal transduction by farnesylating proteins like Ras and Rho.
  • Oncogenic K-RasB variants are implicated in most Ras-related human cancers and are high-affinity FTase substrates.
  • FTase inhibition demonstrates efficacy in regressing Ras-mediated tumors in preclinical models.

Purpose of the Study:

  • To elucidate the structural basis of K-Ras4B peptide substrate binding to FTase.
  • To understand the role of metal ions, specifically zinc, in the prenyltransferase reaction mechanism.
  • To provide insights for structure-based design of novel FTase inhibitors.

Main Methods:

  • Co-crystallization of rat FTase with farnesyl diphosphate analogs and K-Ras4B peptide substrates.
  • X-ray crystallography to determine the structures of four ternary complexes.
  • Analysis of peptide conformation and metal ion coordination within the FTase active site.

Main Results:

  • The Ca(1)a(2)X motif of K-Ras4B peptide binds in an extended conformation, coordinating active site zinc.
  • The polybasic region of K-Ras4B peptide adopts a type I beta turn, enhancing substrate affinity.
  • Zinc removal alters peptide conformation, while manganese binds to the diphosphate mimic.

Conclusions:

  • Zinc is critical for productive Ca(1)a(2)X peptide binding, defining the active conformation.
  • The observed beta-turn in NMR studies may represent a zinc-uncoordinated state.
  • Structural insights facilitate the design of optimized inhibitors targeting Ca(1)a(2)X protein prenyltransferases.

Related Concept Videos